Private equity deal activity in the pharmaceutical industry in Middle East and Africa increased in 2023

In value terms, private equity deal activity in Middle East and Africa decreased by 30% in Q2 2023 compared with the previous quarter’s total of $71.3m. Related deal volume increased by 300% in Q2 2023 versus the previous quarter.

The top-ranked financial advisors supporting these private equity deals in Middle East and Africa in Q2 2023 were Deloitte Touche Tohmatsu; Hc Securities & Investment S.A.E.; PwC India with 1, 1, 1 deals respectively.

The top-ranked legal advisors supporting these private equity deals in Middle East and Africa Q2 2023 were Asafo & Co.; Freshfields Bruckhaus Deringer; Hilmi Law Firm with 1, 1, 1 deals respectively.

For further understanding of GlobalData’s Pharma Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.

This content was updated on 18 July 2023

Ketamine shows complex influence on social cognition in schizophrenia, study reveals

Researchers from the University of Bonn delve into the complex relationship between ketamine and social cognition deficits in schizophrenia, revealing both promising and cautionary insights.

October 13, 2023

Summer Reading List for Healthcare Professionials

Summer has officially arrived, which means it’s time to kick back, take the scrub cap off, and enjoy the sunshine. If you’re in need of

June 29, 2023

Researchers develop an analytical tool that could lead to lead to noninvasive “liquid biopsies”

Biopsies are clinical tools commonly used to diagnose a variety of diseases or to monitor tissue for abnormal growth or even rejection of a transplant.

July 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.